Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
Background Reduction in glucocorticoid exposure is the primary benefit of new biologic treatments in severe asthma, but there is currently no evidence that reduction in glucocorticoid exposure corresponds to a proportionate reduction in associated toxicity. Objectives To use the validated Glucocorti...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |